Thalidomide-O-amido-C3-NH2 TFA
CAS No. 2022182-58-5
Thalidomide-O-amido-C3-NH2 TFA( Cereblon Ligand-Linker Conjugates 16 TFA | E3 Ligase Ligand-Linker Conjugates 52 TFA )
Catalog No. M28569 CAS No. 2022182-58-5
Thalidomide-O-amido-C3-NH2 TFA is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 32 | In Stock |
|
| 25MG | 59 | In Stock |
|
| 50MG | 83 | In Stock |
|
| 100MG | 137 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameThalidomide-O-amido-C3-NH2 TFA
-
NoteResearch use only, not for human use.
-
Brief DescriptionThalidomide-O-amido-C3-NH2 TFA is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology.
-
DescriptionThalidomide-O-amido-C3-NH2 TFA is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology.
-
In Vitro——
-
In Vivo——
-
SynonymsCereblon Ligand-Linker Conjugates 16 TFA | E3 Ligase Ligand-Linker Conjugates 52 TFA
-
PathwayOthers
-
TargetOther Targets
-
Recptorplatelet-activating factor (PAF)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2022182-58-5
-
Formula Weight502.403
-
Molecular FormulaC20H21F3N4O8
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (248.81 mM)
-
SMILESOC(=O)C(F)(F)F.NCCCNC(=O)COc1cccc2C(=O)N(C3CCC(=O)NC3=O)C(=O)c12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Rylander R, et al. Modulation of pulmonary inflammation after endotoxin inhalation with a platelet-activating factor antagonist (48740 RP). Int Arch Allergy Appl Immunol. 1988;86(3):303-7.
molnova catalog
related products
-
n-acetylciprofloxaci...
n-acetylciprofloxacin is inhibitor of H37Rv.
-
6-Methoxy-2-naphthoi...
Used as pharmaceutical intermediates.
-
Moxonidine
Moxonidine is a selective agonist at the imidazoline receptor subtype 1, used as antihypertensive agent.
Cart
sales@molnova.com